ADM and neoplasm: Studies have revealed that adrenomedullin derived from TAMs promotes tumor growth through activation of the endothelial nitric oxide synthase (eNOS) signaling pathway, and inhibition of adrenomedullin receptors on TAMs ultimately suppresses tumor growth [58,59].